Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company

PfizerPfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord Pharma

Endpoints NewsOtsuka touts new IgAN evidence as it seeks full approval for Voyxact

AgilentA Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st

Charles RiverCharles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWS

Endpoints NewsActing FDA chief isn't interested in permanent role

Clinical OMICsPost-Stroke Arm Immobility Improved with Spinal Cord Stimulation

Lonza NewsStipple Bio and Lonza Agree to Focus on Advancing Oncology ADC Therapies - Genetic Engineering and Biotechnology News

PfizerPfizer strikes $10.5 billion oncology deal with Chinese biotech - Life Sciences Intellectual Property Review

Clinical OMICsInfant Brain Development Sheds Light on Parkinson’s Link with Autism

Clinical OMICsAlzheimer’s Genetic Risk Loci: 16 New Candidates

Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meeting

Endpoints NewsDimension seeks up to $750M for third life sciences fund after string of success